Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
Biotech Dental Benelux from Gent, company number BE0544516923, closed financial year 2024 with a result of € 72,357 after tax. For that financial year Biotech Dental Benelux recorded a gross margin of € 202,087 and equity of € 312,406. Compared with financial year 2023, the result moved from € 37,084 to € 72,357. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2025.
€ 312,406
▲ 30% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 72,357
▲ 95% vs 2023
Profit after tax over the fiscal year.
€ 41,993
▼ 14% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 250,906.
People and assets in 2024
1
Average over the fiscal year, from the social balance sheet.
€ 92,660
▼ 8% vs 2023
€ 92,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 226
▼ 35% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 148,176
▲ 83% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 63,987
▲ 15% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 159,576 | € 152,863 | € 147,236 | € 202,087 | ▲ 37% |
| Profit after taxes | € 51,414 | € 42,156 | € 37,084 | € 72,357 | ▲ 95% |
| Equity | € 160,808 | € 202,964 | € 240,049 | € 312,406 | ▲ 30% |
| Total debts | € 203,632 | € 212,301 | € 262,836 | € 291,730 | ▲ 11% |
| Cash | € 110,130 | € 87,758 | € 48,556 | € 41,993 | ▼ 14% |
| Retained profit | € 99,308 | € 141,464 | € 178,549 | € 250,906 | ▲ 41% |
| Balance sheet total | € 364,440 | € 415,265 | € 502,884 | € 604,136 | ▲ 20% |
| Employees (FTE) | 1 | 1 | 1 | 1 |
Key figures of Biotech Dental Benelux, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Biotech Dental Benelux?
What happened at Biotech Dental Benelux in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 72,357 (▲ 95% vs 2023). filed late Source: NBB ↗
- Philippe Veran stepped down as director. NBB
- Guy De Vreese stepped down as director. NBB
- Philippe Veran became a director. NBB
- Guy De Vreese became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 51,414 profit in 2021 to € 72,357 profit in 2024.
Paid € 80,071 in corporate taxes since 2021.
Best year ever: 2024, with € 72,357 profit.
On average € 202,100 of value added per employee in 2024.
A new publication or filing at Biotech Dental Benelux? We notify you, reason included.
Follow Biotech Dental BeneluxDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of remedent comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Biotech Dental BeneluxThe shares are held by remedent (50%).
Directors
According to the 2024 annual accounts
Philippe Veran
Director
since 2019 · until 2025
Guy De Vreese
Managing director
Also active at: Shane Invest, remedent, LAUSHA, Condor Technologies, Metrics in Balance, Aesthics, DNA Talks, ELEMENTAL +1 more
since 2019 · until 2025
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Zuiderlaan 1-3 box 8
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →PAEPSEM
€ 788,648 revenue · 2025
DE COLVENAER
€ 126,511 revenue · 2025
remedent same network
€ 62,168 revenue · 2025
Condor Technologies same network
€ 14,615 revenue · 2024
Pexip Belgium
€ 1.4 million gross margin · 2025
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0544.516.923
- VAT number
- BE 0544.516.923
- Registered office
- Zuiderlaan 1-3 bus 8, 9000 Gent
- Names & denominations
- Biotech Dental Benelux
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 January 2014
- Peppol
- Not registered
- Activities · NACE
Groothandel in farmaceutische en medische artikelen